VOL. XCIV, NO. 247
WIDE MOAT STOCKS COMPARISON
Stock Comparison
Amazon.com, Inc. vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amazon.com, Inc.
AMZN · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Amazon.com, Inc.'s moat claims, evidence, and risks.
View AMZN analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Amazon.com, Inc. leads (89 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Amazon.com, Inc. has 4 segments (68.2% in Amazon Stores (Retail, Marketplace and Prime)); Pfizer Inc. has 5 segments (37.5% in Primary Care).
- Moat breadth: Amazon.com, Inc. has 6 moat types across 3 domains; Pfizer Inc. has 1 across 1.
Primary market context
Amazon.com, Inc.
Amazon Stores (Retail, Marketplace and Prime)
Online and physical retail, third-party marketplace, fulfillment and membership commerce
Global
Consumers and third-party merchants
Marketplace operator, retailer, membership provider and fulfillment network
68.2%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
37.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Amazon.com, Inc. strengths
Pfizer Inc. strengths
Segment mix
Amazon.com, Inc. segments
Full profile >Amazon Web Services (AWS)
Oligopoly
Amazon Stores (Retail, Marketplace and Prime)
Oligopoly
Advertising Services (Amazon Ads and Retail Media)
Oligopoly
Other Services and Adjacencies
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Hospital and Biosimilars
Competitive
Pfizer CentreOne
Competitive
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.